Your browser doesn't support javascript.
loading
Development of anti-GD2 Antibody-producing Mesenchymal Stem Cells as Cellular Immunotherapy.
Iguchi, Masafumi; Yagyu, Shigeki; Kambe, Kosuke; Higashi, Mayumi; Fumino, Shigehisa; Kishida, Tsunao; Iehara, Tomoko; Mazda, Osam; Tajiri, Tatsuro.
Affiliation
  • Iguchi M; Department of Pediatric Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan; micloud@koto.kpu-m.ac.jp.
  • Yagyu S; Department of Immunology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Kambe K; Department of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Higashi M; Department of Pediatric Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Fumino S; Department of Immunology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Kishida T; Department of Pediatric Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Iehara T; Department of Pediatric Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Mazda O; Department of Immunology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Tajiri T; Department of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Anticancer Res ; 43(6): 2417-2424, 2023 Jun.
Article in En | MEDLINE | ID: mdl-37247922
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mesenchymal Stem Cells / Antibodies, Monoclonal Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Anticancer Res Year: 2023 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mesenchymal Stem Cells / Antibodies, Monoclonal Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Anticancer Res Year: 2023 Document type: Article